Collegium Pharmaceutical, Inc. COLL

22.53 (0.11) (0.49%) as of 25 Sep
Market cap
$737.1M
P/E
14.7×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more TTM periods

757.07 780.57 796.33 808.21
Gross Profit
433.17 463.26 483.18 485.09
Operating Income
156.99 179.64 188.85 157.44
EBT
80.85 92.62 108.24 77.68
Income after Tax
58.44 62.87 74.95 47.92
Net Income Common
58.44 62.87 74.95 47.92
Gross Margin
57.22% 59.35% 60.68% 60.02%
EBIT Margin
20.74% 23.01% 23.71% 19.48%
Net Profit Margin
7.72% 8.05% 9.41% 5.93%
Free Cash Flow Margin
38.21% 41.97% 41.42% 40.62%
EBITDA
381.99 404.64 413.37 390.33
EBIT
156.99 179.64 188.85 157.44

Show all line items

In millions of $ except per-share values · columns are period end dates